iPrime Canaloplasty and iStent Infinite

Show Description +

Billy Pan, MD, presents the case of a patient who had cataract surgery with iStent placement back in 2015. Given uncontrolled IOP despite maximum medical therapy, we decided to pursue a combination of an iPrime Canaloplasty (Glaukos) and the additional placement of iStents via the newly FDA approved Infinite system (Glaukos).

Posted: 3/29/2023

Keywords:

iStent

iPrime Canaloplasty and iStent Infinite

Billy Pan, MD, presents the case of a patient who had cataract surgery with iStent placement back in 2015. Given uncontrolled IOP despite maximum medical therapy, we decided to pursue a combination of an iPrime Canaloplasty (Glaukos) and the additional placement of iStents via the newly FDA approved Infinite system (Glaukos).

Posted: 3/29/2023

Keywords:

iStent

Please log in to leave a comment.

More in Glaucoma

Innovations in Drug Delivery: A Drug Delivering IOL

I. Paul Singh, MD; and Douglas McGraw, DO

A Minimally Invasive Approach to Subconjunctival Filtration

Arsham Sheybani, MD; Christine M. Funke, MD; and Shan C. Lin, MD

Treatment Considerations for a Patient With Cataracts and Normal-Tension Glaucoma

John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO

Uveitis With Glaucoma

Evripidis Sykakis, MD